Epigenetic Regulation of Cardiovascular Disease

Epigenetic regulation of gene expression is important in determining cell fate and identity, and may be factor in altering risk or progression of cardiovascular disease. Discover the latest research on Epigenetic Regulation of Cardiovascular Disease here.

July 24, 2020
Open Access

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease

Scientific Reports
Nobuyuki KobayashiKazuhiro Kondo
July 18, 2020
Open Access

IGF1 gene is epigenetically activated in preterm infants with intrauterine growth restriction

Clinical Epigenetics
Masato KantakeToshiaki Shimizu
August 23, 2020
Open Access

Linking LOXL2 to Cardiac Interstitial Fibrosis

International Journal of Molecular Sciences
Melisse ErasmusRabia Johnson
October 24, 2020
Open Access

Smoking-related changes in DNA methylation and gene expression are associated with cardio-metabolic traits

Clinical Epigenetics
Silvana C E MaasMohsen Ghanbari
July 23, 2020
Open Access

Evaluation of different types of arsenic methylation and its relationship with metabolic syndrome in an area chronically exposed to arsenic

Environmental Analysis, Health and Toxicology
Amir Mohammad KazemifarMaryam Arami
September 30, 2020
Open Access

Mitochondrial DNA copy number can influence mortality and cardiovascular disease via methylation of nuclear DNA CpGs

Genome Medicine
Christina A CastellaniDan E Arking
August 17, 2020
Open Access

Sirt1-PPARS Cross-Talk in Complex Metabolic Diseases and Inherited Disorders of the One Carbon Metabolism

Viola J KosgeiJean-Louis Guéant
August 3, 2020

New Mechanisms of Vascular Dysfunction in Cardiometabolic Patients: Focus on Epigenetics

High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
Samuele AmbrosiniFrancesco Paneni
October 26, 2020
Open Access

SUMO proteins in the cardiovascular system: friend or foe?

Journal of Biomedical Science
Prithviraj Manohar Vijaya ShettyNorbert Frey
September 26, 2020
Open Access

Transcriptional Activation of Matricellular Protein Spondin2 (SPON2) by BRG1 in Vascular Endothelial Cells Promotes Macrophage Chemotaxis

Frontiers in Cell and Developmental Biology
Nan LiYong Xu
August 1, 2020
Open Access

BRG1 Stimulates Endothelial Derived Alarmin MRP8 to Promote Macrophage Infiltration in an Animal Model of Cardiac Hypertrophy

Frontiers in Cell and Developmental Biology
Zilong LiYong Xu
October 13, 2020

Olmesartan alleviates bleomycin-mediated vascular smooth muscle cell senescence via the miR-665/SDC1 axis

American Journal of Translational Research
Yi ZhangLi Zhang
August 28, 2020

Is Any Cardiovascular Disease-Specific DNA Methylation Biomarker Within Reach?

Current Atherosclerosis Reports
Carmen de la RochaGertrud Lund
September 11, 2020

m6 A RNA Methylation in Cardiovascular Diseases

Molecular Therapy : the Journal of the American Society of Gene Therapy
Siyi WuXiang Zhou
September 3, 2020
Open Access

UNC0321 inhibits high glucose induced apoptosis in HUVEC by targeting Rab4

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Jieming Nie

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

© 2020 Meta ULC. All rights reserved